Autoimmune disorder causing joint inflammation
62 matching trials — Updated daily from ClinicalTrials.gov
Rheumatoid Arthritis clinical trial monitoring is the process of systematically tracking new and updated clinical trials related to rheumatoid arthritis on ClinicalTrials.gov, the world's largest registry of clinical studies maintained by the U.S. National Library of Medicine. TrialsAlert scans this database every day, using artificial intelligence to classify each trial by its potential impact on patients with rheumatoid arthritis. Trials are scored across six dimensions including phase importance, breakthrough potential, and patient accessibility. Every Friday, subscribers receive a plain-language research briefing explaining which rheumatoid arthritis trials were added or updated that week, what phase they are in, who is sponsoring them, and why they matter. This replaces the 5 or more hours per week that patients and caregivers typically spend manually searching for clinical trial updates for their condition.
Phase: PHASE4
This study evaluates the safety and effectiveness of ivarmacitinib, a new medication, for patients with rheumatoid arthritis who have not responded well to standard treatments. It aims to provide additional treatment options and improve patient outcomes.
Sponsored by Tongji Hospital | NCT07452445
Phase: PHASE3
This Phase 3 trial is testing a combination of baricitinib and anti-TNF therapy for patients with rheumatoid arthritis who have not responded well to previous TNF inhibitor treatments. This study could offer a new treatment option that may better reduce disease activity for people with difficult-to-treat rheumatoid arthritis. The trial is recruiting in France and Monaco with about 160 participants, focusing on adults with refractory disease.
Sponsored by University Hospital, Bordeaux | NCT04870203
Phase: PHASE2
This study is testing new targeted treatments for adults with moderate to severe rheumatoid arthritis who have not responded well to previous therapies. Participants will receive either one or a combination of investigational drugs or placebo and will be closely monitored for safety and effectiveness.
Sponsored by AbbVie | NCT06972446
We scan ClinicalTrials.gov daily for rheumatoid arthritis trials, classify each by potential impact using AI (breakthrough, notable, or routine), and deliver weekly research briefings explaining what changed and why it matters. Our matching system uses medical synonyms, related treatments, and disease domain classification to ensure you never miss a relevant trial.
Get a weekly briefing with the trials that matter most.